These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 6322975)
41. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Coen DM; Schaffer PA Nat Rev Drug Discov; 2003 Apr; 2(4):278-88. PubMed ID: 12669027 [TBL] [Abstract][Full Text] [Related]
42. [Defense mechanism of viral immunologic escape and its preventive measurements]. Chen W Zhonghua Yi Xue Za Zhi; 1999 Apr; 79(4):314-6. PubMed ID: 11601060 [No Abstract] [Full Text] [Related]
43. Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens. Engelmann I; Petzold DR; Kosinska A; Hepkema BG; Schulz TF; Heim A J Med Virol; 2008 Mar; 80(3):467-77. PubMed ID: 18205230 [TBL] [Abstract][Full Text] [Related]
44. Viruses in human carcinogenesis. McAllister RM Prog Med Virol; 1973; 16():48-85. PubMed ID: 4356898 [No Abstract] [Full Text] [Related]
45. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703 [TBL] [Abstract][Full Text] [Related]
46. [Herpesviruses in man]. Conner B; Glaser R Hautarzt; 1979 Jun; 30(6):331-6. PubMed ID: 222711 [TBL] [Abstract][Full Text] [Related]
48. Comparison of immune responses and viral markers in herpesviruses-associated carcinomas: a review. Henle W; Henle G IARC Sci Publ (1971); 1978; (24 Pt 2):801-13. PubMed ID: 221405 [No Abstract] [Full Text] [Related]
49. The role of viruses in congenital defects. Blattner RJ Am J Dis Child; 1974 Dec; 128(6):781-6. PubMed ID: 4374081 [No Abstract] [Full Text] [Related]
51. Susceptibility of herpesviruses to three nucleoside analogues and their combinations and enhancement of the antiviral effect of acid pH. Fiala M; Chow AW; Miyasaki K; Guze LB J Infect Dis; 1974 Jan; 129(1):82-5. PubMed ID: 4358268 [No Abstract] [Full Text] [Related]
52. Oncogenesis and herpesviruses III. Part 2: Cell-virus interactions, host response to herpesvirus infection and associated tumours, role of co-factors. IARC Sci Publ (1971); 1978; (24 Pt 2):583-1102. PubMed ID: 221380 [No Abstract] [Full Text] [Related]
54. The five human herpesviruses: infection, prevention, and treatment. Galasso GJ; Myers MW Adv Intern Med; 1984; 29():25-58. PubMed ID: 6324554 [No Abstract] [Full Text] [Related]
55. [Latency and reactivation of herpes group viruses]. zur Hausen H Med Klin; 1974 Feb; 69(8):309-12. PubMed ID: 4366266 [No Abstract] [Full Text] [Related]
56. Transformation in vitro by herpesviruses - a review. Pope JH IARC Sci Publ (1971); 1975; (11 Pt 1):367-78. PubMed ID: 190141 [No Abstract] [Full Text] [Related]
57. Monitoring four herpesviruses in unrelated cord blood transplantation. Tanaka N; Kimura H; Hoshino Y; Kato K; Yoshikawa T; Asano Y; Horibe K; Kojima S; Morishima T Bone Marrow Transplant; 2000 Dec; 26(11):1193-7. PubMed ID: 11149730 [TBL] [Abstract][Full Text] [Related]